Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery

被引:221
作者
Alpar, HO
Somavarapu, S
Atuah, KN
Bramwell, V
机构
[1] Univ London, Sch Pharm, Ctr Drug Delivery Res, London WC1N 1AX, England
[2] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool L69 3GE, Merseyside, England
关键词
vaccine delivery; DNA vaccine; protein/peptide delivery; mucosal immunology; vaccination strategy; particulate delivery systems;
D O I
10.1016/j.addr.2004.09.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Biodegradable polymer and particulate carriers have been shown to be of considerable potential for the delivery of peptides, proteins and DNA in animal models. In the context of vaccine delivery to the upper and lower respiratory tracts, the use of mucoadhesive agents offers a strategy for the facilitation of increased residence time and increased vaccine efficacy. Additional concerns addressed here include the potential of uptake of vaccine formulations by the primary olfactory nerves in the nasal cavity, effective delivery to the lung, strategies to maximise the immunopotentiation of candidate vaccine formulations, as well as the evaluation of animal models and interpretation of engendered immune responses in terms of antigen-specific antibody production. Experimental data are presented that demonstrate the potential of muco- and bioadhesive agents in combination with liposomes for intranasal (i.n.) delivery of tetanus toxoid in mice. A delivery system utilising chitosan for the formulation of microspheres by the spray-drying method is described and assessed for intranasal vaccine delivery, and porous particles with potential for pulmonary administration are also outlined. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:411 / 430
页数:20
相关论文
共 142 条
[1]   MEASUREMENT AND COMPUTATION OF MURINE INTERLEUKIN-4 AND INTERFERON-GAMMA BY EXPLOITING THE UNIQUE ABILITIES OF THESE LYMPHOKINES TO INDUCE THE SECRETION OF IGG1 AND IGG2A [J].
AGREWALA, JN ;
RAGHAVA, GPS ;
MISHRA, GC .
JOURNAL OF IMMUNOASSAY, 1993, 14 (1-2) :83-97
[2]  
AKIYAMA Y, 1984, CANCER RES, V44, P5127
[3]   LIPOSOMES AS IMMUNOLOGICAL ADJUVANTS [J].
ALLISON, AC ;
GREGORIADIS, G .
NATURE, 1974, 252 (5480) :252-252
[4]   Nasal delivery of vaccines [J].
Almeida, AJ ;
Alpar, HO .
JOURNAL OF DRUG TARGETING, 1996, 3 (06) :455-467
[5]   IMMUNE-RESPONSE TO NASAL DELIVERY OF ANTIGENICALLY INTACT TETANUS TOXOID ASSOCIATED WITH POLY(L-LACTIC ACID) MICROSPHERES IN RATS, RABBITS AND GUINEA-PIGS [J].
ALMEIDA, AJ ;
ALPAR, HO ;
BROWN, MRW .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1993, 45 (03) :198-203
[6]   Current status of DNA vaccines and their route of administration [J].
Alpar, HO ;
Bramwell, VW .
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS, 2002, 19 (4-5) :307-383
[7]   EFFECTIVENESS OF LIPOSOMES AS ADJUVANTS OF ORALLY AND NASALLY ADMINISTERED TETANUS TOXOID [J].
ALPAR, HO ;
BOWEN, JC ;
BROWN, MRW .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 88 (1-3) :335-344
[8]   Intranasal vaccination against plague, tetanus and diphtheria [J].
Alpar, HO ;
Eyles, JE ;
Williamson, ED ;
Somavarapu, S .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 51 (1-3) :173-201
[9]   MICROSPHERE ABSORPTION BY THE NASAL-MUCOSA OF THE RAT [J].
ALPAR, HO ;
ALMEIDA, AJ ;
BROWN, MRW .
JOURNAL OF DRUG TARGETING, 1994, 2 (02) :147-149
[10]   Cutting edge:: Biasing immune responses by directing antigen to macrophage Fcγ receptors [J].
Anderson, CF ;
Mosser, DM .
JOURNAL OF IMMUNOLOGY, 2002, 168 (08) :3697-3701